palmitoylethanolamide.com.au
HomeResearchBright 2016

N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism

Bright N Okine, Manish K Madasu, Fiona McGowan, Charles Prendergast, Jessica C Gaspar, Brendan Harhen, Michelle Roche, David P Finn. Pain. 2016 Dec;157(12):2687-2696.

Laboratory studyOther animals

Design
Laboratory study
Subjects
Rats given formalin to induce nociceptive behaviour, with PEA injected into the anterior cingulate cortex (ACC)
Dose used in the study
PEA administered directly into the ACC; dose not stated in the abstract
Duration
Not stated in the abstract
What was measured
Formalin-evoked nociceptive behaviour, roles of PPAR-alpha, PPAR-gamma, CB1 and TRPV1 receptors, ACC anandamide levels, and c-Fos expression in amygdala, medulla and spinal cord

What the authors reported

Intra-ACC PEA reduced early formalin-evoked pain behaviour, an effect blocked by a CB1 antagonist but not by PPAR-alpha, PPAR-gamma or TRPV1 antagonists, and PEA raised anandamide levels in the ACC. It also reduced c-Fos expression in the basolateral amygdala but not in other regions tested.

Limits of this study

A rat study using direct brain injection of PEA; it cannot show effect from oral or systemic PEA use in people. Funding and conflicts not stated in the abstract.

Source

PubMed 27649266 · doi:10.1097/j.pain.0000000000000687

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.